Acute myocardial infarction homepage

Sub analysis of PEGASUS-TIMI 54 study shows risk reduction with use of Brilinta in heart attack survivors.-AstraZeneca

AstraZeneca announced results from a new sub-analysis of the Phase III PEGASUS-TIMI 54 trial, demonstrating a risk reduction of 19%...

Added 2 months ago Advocacy news

Are standard medical tests good enough to diagnose heart attacks?

Study reveals the danger of poor diagnosis, which may lead to two-thirds of heart attacks being missed.

Added 4 months ago News trends

Magnetic nanoparticles could help rejuvenate damaged hearts

Search all news articles for Acute myocardial infarction

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Hyperammonaemia

Hyperammonaemia can result in serious neurological damage or death. Could you recognise the signs and symptoms?

Breakthrough Cancer Pain Learning Zone

Watch video highlights from the BeCOn OWN 2017 event, including expert opinion, patient experience and panel discussions in the Breakthrough Cancer Pain Learning Zone.

2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

The management of acute myocardial infarction continues to undergo major changes. Good practice should be based on sound evidence, derived from well-conducted clinical trials.

Added 5 years ago

Acute coronary syndrome

This guideline provides recommendations for the management of patients with ACS within the first 12 hours and up to hospital discharge.

Added 6 months ago

2014 ESC/EACTS Guidelines on myocardial revascularization

In 2014, coronary artery bypass grafting (CABG) celebrates the 50^th anniversary of the first procedures performed in 1964. Thirteen years later, the first percutaneous coronary intervention (PCI) was performed.

Added 3 years ago

Search all guidelines for Acute myocardial infarction

Clinical trials

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease (COMPASS)

The primary purpose of this study is to evaluate whether treatment with rivaroxaban and aspirin or rivaroxaban alone is better than aspirin alone in prevention of heart attacks, stroke or cardiovascular death...

Added 6 years ago

An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome

The purpose of this study is to determine whether rivaroxaban in addition to standard care reduces the risk of the composite of cardiovascular death, myocardial infarction, or stroke in patients...

Added 6 months ago

Search all clinical trials for Acute myocardial infarction

Peter English

Doctor in public health and health protection. Particular interests in vaccination (editor of journal Vaccines in Practice) and health informatics/intelligence. I blog and post in a personal capacity: nothing I write here should be assumed to represent the views of anybody other than ... Read more

The advance decision not to attempt cardiopulmonary resuscitation

Decisions to start cardiopulmonary resuscitation (CPR), or to decide in advance to issue a "do not attempt (cardiopulmonary) resuscitation" (DNAR) notice have always been a hot topic in clinical medicine. It may have become even more so since a recent (June 2014) court decision. This post discusses some of the issues and legalities around DNAR decisions.